| EPB265 | The in-hospital tuberculosis diagnostic cascade and early clinical outcomes among people living with HIV before and during the COVID-19 pandemic ' a prospective multisite cohort study from Ghana | E-poster | Impact of COVID-19 on HIV care |
| EPB266 | The impact of COVID-19 pandemic on HIV service provision in Ukraine | E-poster | Impact of COVID-19 on HIV care |
| PEMOB37 | COVID-related barriers associated with suboptimal adherence during India's second "delta" wave: results from a South India HIV cohort | Poster exhibition | Impact of COVID-19 on HIV care |
| EPE416 | Revisiting sustainable financing for the HIV/AIDS response in the COVID-19 era | E-poster | Impact of COVID-19 on financing for the HIV response |
| EPE417 | A pandemic triad: HIV, COVID-19 and debt in developing countries | E-poster | Impact of COVID-19 on financing for the HIV response |
| EPE418 | Effects of COVID-19 on HIV Financing Prospects in 15 Asian Countries | E-poster | Impact of COVID-19 on financing for the HIV response |
| EPB001 | Factors influencing immune restoration in people living with HIV/AIDS | E-poster | Impact of co-factors (e.g., viral clade, tropism, genetic factors) on disease progression |
| EPB002 | Reduced selection of unfavourable HLA-I in mother-to-child HIV transmission in KwaZulu Natal, South Africa | E-poster | Impact of co-factors (e.g., viral clade, tropism, genetic factors) on disease progression |
| EPA063 | Enhanced functional cytotoxic cell populations in PBMCs from individuals with HIV on treatment with ART and dasatinib | E-poster | Immunotherapy (including broadly neutralizing antibodies) |
| EPA064 | Broadly neutralizing HIV-1 antibodies as a PrEP modality among young sexual minority men: a conjoint experiment | E-poster | Immunotherapy (including broadly neutralizing antibodies) |